The Swiss government met with executives of Roche Holding AG and Novartis AG to discuss the pharmaceutical industry’s situation in light of US tariffs.

The European Union could not say when a joint statement on tariffs with the United States would be ready, nor when the White House would issue an executive or ...

Stocks: European stocks largely ticked upward, gaining ground on Monday's close, as investors awaited inflation data from the U.S. and expected insight from Germany ...

Novartis (NYSE:NVS) (SIX:NOVN) said its experimental antibody ianalumab, used in combination with eltrombopag, achieved the ...

Novartis drew heightened retail chatter on Monday amid reports that Swiss ministers plan to meet this week with top ...

President Trump on Monday signed an executive order extending the tariff truce between the US and China for another 90 days, pushing trade negotiations out to the fall. China also announced the ...

Currently exempt from US tariffs, pharmaceutical manufacturers fear steep surcharges, as promised by the US president on ...

EUROPEAN shares ticked lower on Monday, as investors refrained from making big bets ahead of an eventful week packed with ...

The Swiss government is due to meet this week with pharmaceuticals firms that U.S. President Donald Trump has asked to lower ...

Roche (RHHBY) and Novartis (NVS) are scheduled to meet with Swiss officials this week amid U.S. tariff threats on pharma ...

The Swiss government is engaging with pharma companies Roche and Novartis to address U.S. President Trump's demand for price cuts and to negotiate a 39% tariff on Swiss exports. The discussion follows ...

UNITED STATES consumers probably experienced a slight pickup in underlying inflation in July as retailers gradually raised prices on a variety of items subject to higher import duties. The core ...